By contrast, Faber et al., (2011) reported a poor PFS (4.7 vs. 13.7 months, P=0.007) among patients with low BIM-RNA-expressing NSCLC, which correlated with low BIM protein expression on IHC staining. This evidence concerns the gene BCL2L11 and non-small cell lung carcinoma.